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Laparoscopic cholecystectomy (LC) is the treatment of choice, even in acute
cholecystitis.
1,2 However, there is still a high rate of open conversion and mortality
in patients with high surgical risk, especially when emergency cholecystectomy is
necessary.
3,4 Nevertheless, we need to treat them definitely as early as possible,
because 10 to 30 percent of patients with acute cholecystitis develop life threa-
tening complications such as empyema, gangrene and perforation.
5
Original Article
DOI 10.3349/ymj.2010.51.4.540
pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 51(4):540-545, 2010
Better Treatment Strategies for Patients 
with Acute Cholecystitis and American Society 
of Anesthesiologists Classification 3 or Greater
Sung Su Yun,
1Dae Wook Hwang,
1Se Won Kim,
1Sang Hwan Park,
1
Sang Jin Park,
2Dong Shick Lee,
1and Hong Jin Kim
1
Departments of 1Surgery and 2Anesthesiology, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea.
Purpose: Laparoscopic cholecystectomy is the best treatment choice for acute
cholecystitis. However, it still carries high conversion and mortality rates. The
purpose of this study was to find out better treatment strategies for high surgical
risk patients with acute cholecystitis. Materials and Methods: Between January
2002 and June 2008, we performed percutaneous cholecystostomy instead of
emergency cholecystectomy in 44 patients with acute cholecystitis and American
Society of Anesthesiologists (ASA) classification 3 or greater. This was performed
in 31 patients as a bridge procedure before elective cholecystectomy (bridge
group) and as a palliative procedure in 11 patients (palliation group). Results: The
mean age of patients was 71.6 years (range 52-86 years). The mean ASA
classifications before and after percutaneous cholecystostomy were 3.3 ± 0.5 and
2.5 ± 0.6, respectively, in the bridge group, and 3.6 ± 0.7 and 3.1 ± 1.0, in the
palliation group, respectively. Percutaneous cholecystostomy was technically suc-
cessful in all patients. There were two deaths after percutaneous cholecystostomy
in the palliation group due to underlying ischemic heart disease and multiple organ
failure. Resumption of oral intake was possible 2.9 ± 1.8 days in the bridge group
and 3.9 ± 3.5 days in the palliation group after percutaneous cholecystostomy. We
attempted 17 laparoscopic cholecystectomies and experienced one failure due to
bile duct injury (success rate: 94.1%). The postoperative course of all cholecystec-
tomy patients was uneventful. Conclusion: Percutaneous cholecystostomy is an
effective bridge procedure before cholecystectomy in patients with acute chole-
cystitis and ASA classification 3 or greater.
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INTRODUCTIONFor the last decade, percutaneous cholecystostomy (PC)
has been proposed and accepted as an alternative to emer-
gency cholecystectomy.
6-9 However, even recent publica-
tions dealing with the efficacy or effectiveness of PC did
not provide us clear guideline for PC in acute cholecystitis. 
Since there is no clear guideline for PC and critical
pathway developed for patients with acute cholecystitis,
primary care doctor and surgical trainee in the emergency
center have dilemma to select a good candidate patients for
emergency cholecystectomy or PC. 
Since 1963, American Society of Anesthesiologists
(ASA) classification has been simple, reliable and evi-
dence based method to evaluate surgical risk after general
anesthesia.
10 Moreover, most of clinicians are familiar with
ASA classification in real clinical situation. We decided to
perform PC instead of emergency cholecystectomy in
patients with acute cholecystitis and ASA classification 3
or greater, whether it was for a bridge procedure before
cholecystectomy or palliative purpose. Because surgical
risk after general anesthesia in patients with ASA classifi-
cation 3 is 1.7%
10 which is unacceptable mortality rate after
cholecystectomy, we need to setup better strategies for
high risk patients in our institution. 
We report a 6.5-year prospective experience with PC in
patients with acute cholecystitis and ASA classification
(Table 1) 3 or greater.
Patients and methods
Between January 2002 and June 2008, 622 patients were
presented with acute cholecystitis. We applied ASA
classification to these patients to evaluate surgical risk. The
patients who had ASA classification below 3 were allocat-
ed to elective or emergency surgery and the patients who
had ASA classification 3 or greater were allocated to PC as
a bridge procedure before elective cholecystectomy (bridge
group) and as a palliative procedure (palliation group)
depending on clinical situation. 
The diagnosis of acute cholecystitis was established on
the basis of clinical and laboratory findings. Patients who
had more than two of the following findings were defined
as having acute cholecystitis: fever > 37.5˚C, pain for more
than 48 hours, gallbladder wall thickness > 4 mm, and
abdominal distension, pericholecystic abscess. Assignment
of the ASA classification was carried out by two anesthe-
siologists, one of which at least was a consultant. The ASA
classification system used in this paper is shown in Table 1.
ASA classification 3 or greater was defined depending
on significant comorbidities. Significant cardiac comor-
bidity included severe ischemic heart disease (as evidenced
by coronary angiography, history of frequent/unstable an-
gina or myocardial infarction within 6 months of presenta-
tion), dysrhythmias causing hemodynamic instability, or
clinical and/or echocardiographic evidence of poor ventri-
cular function. Significant respiratory disease included a
respiratory condition causing clinically evident respiratory
distress, hypoxemia, or a peak expiratory flow rate of less
than 40% expected. Renal impairment was defined by the
presence of an elevated serum creatinine level despite
adequate fluid resuscitation. Significant central nervous
system disease included a neurological condition prevent-
ing patients from attending to their personal activities of
daily living, or a history of cerebrovascular accidents.
11 We
defined biliary sepsis-induced leucopenia, thrombocyto-
penia and/or hypotension with response to pressor drugs as
an ASA classification 3 and hemodynamic instability not
respond to pressor drugs and/or mental change as an ASA
classification 4.
We evaluated patient characteristics, complication rates
after PC, ASA classification change before and after PC,
resumption of oral intake after PC, and the success rate of
LC. PC was performed under sterile conditions using
ultrasound guidance. After local anesthesia was achieved
with 1% subcutaneous lidocaine, a 10 F or 8.5 F nephros-
tomy, cope loop, or multipurpose catheter was placed in
the gallbladder, using the Seldinger exchange technique,
and secured in place. The transperitoneal route was used in
17 patients, while the transhepatic route was used in 27
patients. Aspirated material was sent to the clinical labora-
tory for culture. This study was approved by the Ethics
Committee, Yeungnam University Medical Center, Dae-
gu, Korea.  
Statistical analysis
Results are reported as means ± SDs. Differences were
tested using the Chi-square test. p values less than 0.05 were
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MATERIALS AND METHODS
Table 1.American Society of Anesthesiologists (ASA) Classification
I Patient with no limitation of activities; they suffer no symptoms from ordinary activity.
II Patients with slight, mild limitation of activity; they are comfortable with rest or with mild exertion.
III Patients with marked limitation of activity; they are comfortable only at rest.
IV
Patients who should be at complete rest, confined to bed or chair; any physical activity brings 
on discomfort and symptoms occur at rest.
V Moribund patient not expected to survive 24 hrs with or without an operation.considered statistically significant.
Forty-four patients (7.1%) among 622 patients with acute
cholecystitis had ASA classification 3 or greater. We
performed PC as a bridge procedure before elective chole-
cystectomy (bridge group) in 31 patients and as a palliative
procedure in 11 patients (palliation group). There were 2
deaths after PC in the palliation group due to underlying
disease (ischemic heart disease and multiple organ failure).
We believe that these deaths were not related with PC or
biliary sepsis. 
The mean patient age at the time of PC was 71.6 years
(range 52-86 years). The mean age of the bridge group was
70.7 ± 10.5 years, and that of the palliation group was 73.1
± 8.8 years. Surgical risk factors in enrolled patients are
described in Table 2. The indications for PC were signifi-
cant patient comorbidity with high anaesthetic risk (n = 38)
and biliary sepsis (n = 6). The mean ASA classifications
before and after PC were 3.3 ± 0.5 and 2.5 ± 0.6 in the
bridge group; and 3.6 ± 0.7 and 3.1 ± 1.0 in the palliation
group, respectively (Table 3). PC was technically success-
ful in all patients (success rate: 100%), with 4 complications
(rate: 9.1%; one case of PC site infection and 3 cases of PC
site bleeding). However, all complications responded well
to conservative treatment.
The average hospital stay after PC was 14.3 ± 14.5 days
in the bridge group and 16.0 ± 17.1 days in the palliation
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Table 3.Comparison of Bridge Group and Palliation Group
Bridge group Palliation group
Age 70.7 ± 10.5 yrs 73.1 ± 8.8 yrs
ASA
Before PC After PC Before PC After PC
3.3 ± 0.5 2.5  ± 0.6 3.6 ± 0.7 3.1 ± 1.0
Hospital stay 14.3 ± 14.5 days 16.0 ± 17.1 days
Resumption of oral intake 2.9 ± 1.8 days 3.9 ± 3.5 days
PC, percutaneous cholecystostomy; ASA, American Society of Anesthesiologists.
Table 2.Associated Comorbidities in 44 Patients
Disease No. of patients (%)
Malignancy 3 (3)
Pulmonary 32 (32.3)
Vascular 3 (3)
Renal 6 (6.1)
Cardiac 6 (6.1)
Ischemic heart disease 14 (14.1)
Hypertension 17 (17.2)
Diabetes mellitus 11 (11.1)
Other 7 (7.1)
Total 99 
Total patients who 
underwent PC
n = 44
Died of ischemic heart disease
or multiple organ failure
n = 2
Bridge group
n = 31
Patients declined surgery
n = 3
Palliation group
n = 14
Patients underwent 
elective surgery
n = 28
Successful LC
n = 16
OC
n = 11
LC conversion to OC
n = 1
Fig. 1.Flow chart of outcomes in 44 patients with acute cholecystitis undergoing percutaneous cholecystostomy. PC, percutaneous cholecystostomy; LC, laparoscopic
cholecystectomy; OC, open cholecystectomy.
RESULTSgroup. Resumption of oral intake was possible at 2.9 ± 1.8
days after PC in the bridge group and at 3.9 ± 3.5 days after
PC in the palliation group, except for in 2 patients who
died due to underlying diseases (Table 3). We tried 17 LCs
at 25.1 ± 19.8 days after PC and failed in one case due to
bile duct injury (success rate: 94.1%). The mean hospital
stay after LC was 5.1 ± 1.8 days, and the mean operative
time for LC was 101.6 ± 36.8 minutes, which was not
longer than that for LC in the setting of acute cholecystitis
in our hospital. The postoperative course of all patients who
underwent LC and open cholecystectomy was uneventful. 
In the bridge group (n = 31), 3 patients who declined
surgery were reallocated to the palliative group. Elective
cholecystectomy was performed in 28 patients, including
laparoscopic (16 patients) and open (12 patients) cholecys-
tectomy (Fig. 1).
In the palliation group (n = 14), 3 patients were lost in
our follow up program and 4 patients were dead due to
esophageal cancer bleeding, ischemic heart diseases and
disseminated malignancy at 27th, 36th, 132th and 148th
days after PC. In the remaining 7 patients, we performed
tubography through the PC tube to see the cystic duct
function. We removed PC tube at 141 ± 91 days after PC
without complication in 5 patients, including 3 patients
with acalculous cholecystitis. Despite of minor symptoms,
they survived without acute severe cholecystitis at 23.8  ±
15.4 months. One of two patients, who did not have patent
cystic duct, received repeat PC at 6 months after spon-
taneous removal and the other patient survived at 24
months after removal with collapsed chronic cholecytitis.
In contrast to physicians in the early era of laparoscopic
cholecystectomy (LC), most of current surgeons agree that
LC is also the treatment of choice in acute cholecystitis
with similar operation time, shorter hospital stay and com-
plication rate, compared with open cholecystectomy. Nev-
ertheless, there have been two issues concerning the high
rate of mortality and open conversion after LC in high risk
patients with acute cholecystitis.
3,4,12-16
We focused on two points in determining the better
strategy for treating high risk patients with acute cholecy-
stitis. First, we evaluated surgical risk factors to reduce
mortality and sought how to circumvent the septic process
and pain. Second, we sought how to reduce open conver-
sion rate.
We believe that mortality after LC derives usually from
underlying comorbidities and sepsis. Even though there are
various methods to evaluate critically ill patients, ASA
classification is a well established and evidence-based
method for determining surgical risk after general anes-
thesia. Furthermore, most of clinicians, especially surgeon
and primary care doctors in emergency center, are familiar
with that. We know that ASA class 3 and 4 patients have
mortality rates of 1.7% and 4.3%, respectively.
10 Before
the era of LC, surgeons noted an approximately 0.5%
mortality rate after open cholecystectomy.
17,18 Hence, if a
procedure carries a mortality rate above 0.5%, alternative
treatment should be considered. 
The appropriate management to circumvent the septic
process and relieve pain in critically ill patients has been an
another issue. Because some patients (10 to 30%) with acute
cholecystitis develop life threatening complications such
as empyema, gangrene or perforation,
5 a question still
remains whether PC is superior to conservative treatment
in high risk patients with acute cholecystitis. To the best of
our knowledge, there has been only one prospective
randomized study by Hatzidakis, et al.
19 Even though they
reported similar response and mortality rate in both groups,
PC was recommended when there was no response after 3
days of conservative treatment. We decided to perform PC
in high risk patients because PC has been accepted as a
good alternative to LC in that it avoids septic process and
relieves pain. Eventually, we could have time to evaluate
and treat combined comorbidities after PC.
6,8,20-23
Many authors emphasized that the importance of an
early definitive treatment in patients with acute cholecys-
titis, especially if an operation is attempted laparoscopi-
cally.
14-16 The longer LC is delayed, the more fibrosis and
adhesion in operation field which makes operation difficult. 
Before the start of this study, we clearly defined the
definition of ASA classification in our institution with
anesthesiologists (see materials and methods). We evaluat-
ed surgical risk of all patients with acute cholecystits,
depending on ASA classification. During the study period,
fortunately there was no mortality among 412 patients with
ASA classification less than 3 who were allocated to surgery
(emergency or elective). We performed PC in 44 patients
with ASA classification 3 or greater and classified them as
a bridge group (bridge to definite surgery) or palliation
group, depending on clinical situation. Allocation to the
palliative group was determined by the attending surgeon,
based on life expectancy, medical comorbidities, patient
and family desire. All surgeries in the bridge group were
done under elective schedule as early as possible to reduce
the open conversion rate. 
In our present study, PC was associated with no morta-
lity and low morbidity. We preferred a transhepatic appro-
ach, despite potential risks of pneumothorax, intrahepatic
bleeding, hemobilia, and fistula formation, because this
approach minimizes the risk of intraperitoneal bile leakage
and colon injury.
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DISCUSSIONResumption of oral intake was possible at 2.9 ± 1.8 days
after PC in the bridge group and at 3.9 ± 3.5 days after PC
in the palliation group. The mean ASA classifications
before and after PC were 3.3 ± 0.5 and 2.5 ± 0.6, in the
bridge group, and 3.6 ± 0.7 and 3.1 ± 1.0 in the palliation
group, respectively. Early oral intake and improvement in
ASA classification suggest that PC is an effective alterna-
tive to emergency cholecystectomy.
Hospital stays after PC in this study were longer than
those in other reports.
21,24,25 In Korea, patients tend to stay in
the hospital longer because most hospital expenses are
paid by the socialized Korean medical insurance system.
The rates of conversion to open surgery in earlier studies
26-29
were high (more than 10%), whereas the success rate of
LC (94.1%) after PC in the current study was acceptable,
and postoperative courses after LC and open cholecystec-
tomy were uneventful. It is not unrealistic to expect that
we can reduce open conversion rate by doing LC as early
as possible, and Tsumura, et al.
30 reduced open conversion
rate from 9.6% to 3.3% by LC after PC.
In palliation group, we tried to remove PC after tubogra-
phy, and we were able to remove PC tube in 5 patients with
patent cystic duct. For acalculos cholecystitis, there are
studies that cholecystecomy is not required because acal-
culous cholecystitis did not recur after PC.
31,32 Sugiyama, et
al.
33 and Van Steenbergen, et al.
34 reported that, after cessa-
tion of drainage, acute cholecystitis relapsed in 33% and
25% of their elderly patients with gallbladder stones, respec-
tively. For patients with acute calculous cholecystitis who
are not good candidate for surgery, we need to consider ano-
ther treatment options such as contact dissolution therapy,
endoscopic gallbladder stent and/or percutaneous lithotripsy. 
In conclusion, better treatment strategies for high risk pati-
ents with acute cholecystitis are evaluation of surgical risk
with ASA classification at first, and if ASA classification
is 3 or greater,  perform PC to reduce septic symptoms, to
have time for evaluation and treatment of comorbidities, sub-
sequently, allocate them to a bridge or palliative group de-
pending on clinical decision, and try to definite surgery under
elective schedule as early as possible in the bridge group.
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